期刊文献+

TGF-β_1及Smad4蛋白在子宫颈癌组织中的表达及其意义 被引量:7

Expression of Transforming Growth Factor β_1 and Smad4 in Cervical Carcinoma and Its Clinical Significance
下载PDF
导出
摘要 目的探讨转化生长因子-β(TGF-β)信号传导通路中TGF-β1和Smad4在子宫颈癌组织中的表达及其临床意义。方法应用免疫组化SP法检测78例宫颈癌和20例正常宫颈组织中TGF-β1和Smad4的表达情况,分析其与宫颈癌各临床病理因素的关系。结果宫颈癌组织中TGF-β1的表达明显高于正常宫颈组织,且表达与宫颈癌原发灶大小、临床分期、病理分级、淋巴转移有关,与患者年龄及组织类型无关;宫颈癌组织中Smad4的表达明显低于正常宫颈组织,且表达与临床分期、病理分级、淋巴结转移有关,与患者年龄、原发灶大小及组织类型无关。宫颈癌组织中TGF-β1和Smad4的表达呈负相关。结论TGF-β1和Smad4共同在宫颈癌的发生发展过程中发挥重要的作用。 Objective To investigate the expression and its clinical significant of TGF-β1 and Smad4 protein in cervical carcinoma. Methods The expression of TGF-β1 and Smad4 was analyzed in 78 cervical carcinoma tissues and 20 normal cervical epithelium by immunohistochemical SP method. The expression of TGF-β1 and Smad4 was then correlated with clinicopathological characteristics. Result TGF-β1 expression in cervical carcinoma was significantly higher than that in normal cervical epithelium, and was associated with primary tumor size, clinical stage, pathological grade, lymph node metastasis, but not associated with patient' s age and histological type ;Smad4 expression in cervical carcinoma was significantly lower than that in normal cervical epithelium,and was associated with clinical stage, pathological grade, lymph node metastasis, but not associated with patient's age, primary tumor size and histological type. The expression of TGF-β1 had a negative correlation with that of Smad4. Conclusion TGF-β1 and Smad4 may play an important role in the oncogenesis and development of cervical carcinoma.
作者 张競 李胜泽
出处 《实用癌症杂志》 2008年第5期465-468,共4页 The Practical Journal of Cancer
关键词 宫颈癌 转化生长因子-Β SMAD4 免疫组织化学 Cervical carcinoma Transforming growth factor β (TGF-β) Smad4 Immunohistochemistry
  • 相关文献

参考文献13

  • 1Hirayama D, Fujinori T, Satonata K, et al. Immunohistochemical study of epidermal growth factor and transforming growth factorβ in penetrating type of early gastric cancer [J]. Human Pathol,1992,23(6) :681.
  • 2Korchynskyi O, Landstrom M, Stoika R, et al. Expression of smad protein in human colorectal cancer [ J ]. Int J Cancer, 1999,82(2) :197.
  • 3Hahn SA, Schuhe M, Hoque ATMS, et al. Dpc4 a candidate tumor suppressor gene at human chromosome 18q21.1 [ J ]. Science, 1996,271 (5247) :350.
  • 4Kaminska B, Wesolowska A, Danilkiewicz M. TGF β signalling and its role in tumour pahtogenesis [ J ]. Acta Biochim Pol,2005,52 (2) :329.
  • 5Minoru F, Tatsuya M, Yasuyuki F, et al. Plasma level of transforming growth factorβ1 measured from the azygos vein predicts prognosis in patients with esophageal cancer[ J]. Clin Cancer Res ,2004,10:2738.
  • 6Liu Y,Zhong X,Li W,et al. The role of Spl in the differential expression of transforming growth factor β receptor type Ⅱ in human breast adenocarcinoma MCF-7 cells[ J]. J Biol Chem,2000,275 (16) : 12231.
  • 7Frnk SP, Swinler SE, Lutterbaugh JD, et al. Transforming growth factor-β induced growth inhibition in a Smad4 mutant colon adenoma cell line [ J ]. Cancer Res, 2001,61 (1) :256.
  • 8Christina H, Miriam B, Juergen D, et al. Smad4-expression is decreased in breast cancer tissues:a retrospective study [ J]. BMC Cancer Res,2006 ,6 :25.
  • 9Hazelbag S, Fleuren GJ, Baelde J J, et al. Cytokine profile of cervical cancer cells[ J]. Gynecol Oncol,2001,83 (2) :235.
  • 10Farley U, Fray K, Nycun L, et al. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kipl) [J]. Gynecol Oncol,2000,7S(2) :113.

二级参考文献7

  • 1Enomoto T, Fujita M, Inoue M, et al. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium[J]. Cancer Res, 1993,53(8):1 883.
  • 2Hruban RH, Offerhaus GJA, Kern SE, et al. Tumor-suppressor genes in pancreatic cancer[J]. J Hepatobiliary Pancreat Surg, 1998,5:383.
  • 3Pasche B. Role of transforming growth factor beta in cancer[J]. J Cell Physiol, 2001, 186(2): 153.
  • 4Wilentz RE, Su GH, Dai JL, et al. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation[J]. Am J Pathol, 2000,156(1):37.
  • 5Massague J, Chen YG. Controlling TGF-beta signaling[J]. Genes Dev, 2000 , 14(6):627 .
  • 6Kim YH,Lee HS,Lee HJ,et al. Prognostic significance of the expression of smad4 and Smad7 in human gastric carcinomas[J]. Annals of Oncology,2004,15(1):574.
  • 7Sohn TA, Su GH, Ryu B, et al. High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells[J]. Ann Surg, 2001 ,233(5):696.

共引文献1

同被引文献78

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部